A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Non ancora tradotto Non ancora tradotto
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2013

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
The purpose of the study is to evaluate dose response of JNJ-54781532 in participants with moderately to severely active ulcerative colitis (UC).
Epistemonikos ID: 0a040cfa2676364dab63fcd60f498a59567f2b63
First added on: Mar 23, 2022